Send feedback

NPHP4 p.Thr976Ile

c.2927C>T · rs756219438 · VCV1284771

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 3 submitters
AlphaMissense
likely pathogenic
0.6515 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00424%, nfe)
Missense predictors
3/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
nephronophthisis

Computational evidence

Protein change
AlphaMissense0.6515likely pathogenic
REVEL0.854moderately pathogenic-leaning
SaProtLLR -11.67damaging
⇒ AlphaMissense, REVEL and SaProt all call this damaging.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 9.6GERP 0.53, phastCons 1
Regional constrainto/e 1.02unconstrained · MANE · 123 kb · p 0.49 · regional, not allelic
Overall
CADD23.9PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00424% European (non-Finnish) · 50/1,179,894 alleles
Filtering AF 0.00326% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00294%
Overall 0.00434% 70/1,612,456 alleles · very rare exomes 64/1,460,248 · genomes 6/152,208 · joint denominator
Ancestry group Frequency 1 in
Finnishnot grpmax-eligible 0.024% 4,173
Ashkenazi Jewishnot grpmax-eligible 0.00676% 14,801
European (non-Finnish)grpmax 0.00424% 23,598
Remaining individualsnot grpmax-eligible 0.0032% 31,225
Admixed American 0.00167% 60,012

Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
NPHP4
Protein
p.Thr976Ile
Coding
c.2927C>T
MANE Select
NM_015102
dbSNP
rs756219438
Type
single nucleotide variant
Location
chr1:5874991 (GRCh38)
Gene constraint
LOEUF 1.183 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 72.44
Residue 976
the 'sufficient for basal bodies localization' region
Full NPHP4 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

nephronophthisis — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Nephronophthisis (Orphanet):

Inheritance
Autosomal recessive
Onset
Adolescent, Adult, Antenatal, Childhood, Infancy, Neonatal
Prevalence
1-9 / 100 000 (Finland)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/nphp4-p-thr976ile (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown